Degree of mucositis and duration of neutropenia are the major risk factors for early post-transplant febrile neutropenia and severe bacterial infections after reduced-intensity conditioning-Reference-Cited by-同舟云学术

Degree of mucositis and duration of neutropenia are the major risk factors for early post-transplant febrile neutropenia and severe bacterial infections after reduced-intensity conditioning

Published:2011-12-13 Issue:1 Volume:88 Page:46-51
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Facchini Luca,Martino Rodrigo,Ferrari Angela,Piñana José L.,Valcárcel David,Barba Pere,Granell Miguel,Delgado Julio,Briones Javier,Sureda Anna,Brunet Salut,Sierra Jorge

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2011.01724.x/fullpdf

Reference31 articles.

1. Lower infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma;Bachanova;Bone Marrow Transplant,2009

2. Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation;Hori;Biol Blood Marrow Transplant,2004

3. Reduced intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem transplantation;Martino;Bone Marrow Transplant,2001

4. Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation;Meijer;Transpl Infect Dis,2004

5. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study;Junghanss;Biol Blood Marrow Transplant,2002

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucositis-associated bloodstream infections in adult haematology patients with fever during neutropenia: risk factors and the impact of mucositis severity;Supportive Care in Cancer;2024-08-08

2. Recent advances in cancer therapy‐associated oral mucositis;Oral Diseases;2024-07-05

3. Application of big data analyses to compare the impact of oral and gastrointestinal mucositis on risks and outcomes of febrile neutropenia and septicemia among patients hospitalized for the treatment of leukemia or multiple myeloma;Supportive Care in Cancer;2023-03

4. Concordance of the WHO, RTOG, and CTCAE v4.0 grading scales for the evaluation of oral mucositis associated with chemoradiation therapy for the treatment of oral and oropharyngeal cancers;Supportive Care in Cancer;2021-03-31

5. ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy;Cancer Chemotherapy and Pharmacology;2020-08